CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of MT-601 administration to patients with Relapsed or Refractory Lymphoma. The starting dose administered is 200 x 10\^6 cells (flat dosing)....
Phase 1
Kansas City, Kansas, United States and 6 other locations
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Overland Park, Kansas, United States and 89 other locations
Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracycline containing frontline immu...
Phase 3
Kansas City, Kansas, United States and 66 other locations
Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...
Phase 3
Fairway, Kansas, United States and 126 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Fairway, Kansas, United States and 215 other locations
to assess the efficacy and safety of golcadomide in combination with rituximab in participants with newly diagnosed advanced stage Follicular Lymphoma...
Phase 2
Fairway, Kansas, United States and 64 other locations
This is a multi-center, phase II study to determine the efficacy and safety of tisagenlecleucel in adult patients with relapsed or refractory FL.
Phase 2
Kansas City, Kansas, United States and 29 other locations
safety of ibrutinib given in combination with bendamustine and rituximab in patients 65 years of age or older with newly diagnosed mantle cell lymphoma...
Phase 3
Westwood, Kansas, United States and 203 other locations
(firi-cel), a CD22-directed autologous Chimeric Antigen Receptor (CAR) T-cell therapy for the treatment of relapsed or refractory large B-cell lymphoma...
Phase 2
Westwood, Kansas, United States and 29 other locations
This is a study for participants with a type of blood cancer called mantle cell lymphoma (MCL). The main purpose is to compare pirtobrutinib...
Phase 3
Kansas City, Missouri, United States and 226 other locations
Clinical trials
Research sites
Resources
Legal